missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human CD177 Control Fragment Recombinant Protein
Click to view available options
Menge:
100 μL
Packungsgröße:
100 Mikroliter
Beschreibung
Highest antigen sequence indentity to the following orthologs: Mouse (49%), Rat (49%). This recombinant protein control fragment may be used for blocking experiments. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
CD177 (NB1/HNA-2a and PRV-1 form) is a GPI-anchored glycoprotein present mainly on neutrophils. Its plasma membrane expression is increased during pregnancy and and inflammation or after G-CSF application. Ligand of CD177 has been identified as CD31 (PECAM-1). CD177 participates in neutrophil transmigration and seems to be also a pro-proliferative molecule. The antibodies against CD177 can be involved in neonatal alloimmune neutropenia (NAN).

Spezifikation
Spezifikation
Zugriffsnummer | Q8N6Q3 |
Konzentration | ≥5.0 mg/mL |
Zur Verwendung mit (Anwendung) | Blocking Assay, Control |
Zusammensetzung | 1 M urea, PBS with no preservative; pH 7.4 |
Gen-ID (Entrez) | 57126 |
Name | Human CD177 Control Fragment |
Menge | 100 μL |
Kennzeichnung | RUO |
Gen-Alias | 1190003K14Rik; CD177; CD177 antigen; CD177 molecule; cell surface receptor; HNA2A; HNA-2 A; Human neutrophil alloantigen 2 A; NB1; NB1 glycoprotein; NB1 GP; Pdp3; Polycythemia rubra vera protein 1; PRV1; PRV-1; RGD1562941; UNQ595/PRO1181 |
Gebräuchliche Bezeichnung | CD177 |
Mehr anzeigen |
Berichtigung von Produktinhalten
Bitte geben Sie uns Ihr Feedback zu den Produktinhalten, indem Sie das folgende Formular ausfüllen.
Name des Produkts
Invitrogen™ Human CD177 Control Fragment Recombinant Protein >
Haben Sie Verbesserungsvorschläge?Übermitteln Sie eine inhaltliche Korrektur